Daniel Gelfond

Clinical Mechanism of the Cystic Fibrosis Transmembrane Conductance Regulator Potentiator Ivacaftor in G551D-mediated Cystic Fibrosis

Steven M. Rowe, Sonya L. Heltshe, Tanja Gonska et al. · American Journal of Respiratory and Critical Care Medicine · 2014 · 498 citations

Medicine, Pharmacology, Pharmacotherapy +17

Natural history of celiac disease autoimmunity in a USA cohort followed since 1974

Carlo Catassi, Debby Kryszak, Bushra Bhatti et al. · Annals of Medicine · 2010 · 366 citations · Full text

Life Sciences, Immunology, Internal Medicine +16

Intestinal pH and Gastrointestinal Transit Profiles in Cystic Fibrosis Patients Measured by Wireless Motility Capsule

Daniel Gelfond, Chang‐Xing Ma, Jack Semler et al. · Digestive Diseases and Sciences · 2012 · 175 citations

Medicine, Clinical Sciences, Physiology +13

Vitamin and Mineral Status in Patients With Inflammatory Bowel Disease

Razan Alkhouri, Humaira Hashmi, Robert D. Baker et al. · Journal of Pediatric Gastroenterology and Nutrition · 2012 · 166 citations

Public Health, Nutrition, Nutritional Sciences +16

Impact of CFTR Modulation on Intestinal pH, Motility, and Clinical Outcomes in Patients With Cystic Fibrosis and the G551D Mutation

Daniel Gelfond, Sonya L. Heltshe, Chang‐Xing Ma et al. · Clinical and Translational Gastroenterology · 2017 · 150 citations · Full text

Medicine, Pharmacology, Physiology +17